JakartaGlobe-May 16

The Health Ministry has suspended the distribution of around 450,000 doses of the AstraZeneca vaccine on Sunday and submitted the batch to Indonesia’s drug authority for further tests following the death of a 22-year-old man who took the vaccine shot eleven days ago. Food and Drug Administration (BPOM) would conduct toxicity and sterility tests on the batch before clearing them for use, Widyawati, the Health Ministry’s head of communication and community service, said in a statement on Sunday. Widyawati said that AstraZeneca batches other than CTMAV547 are safe to use so that people don’t need to hesitate to receive their shots. Indonesia received batch CTMAV547 batch from AstraZeneca on April 26 as part of 3.85 million vaccine doses procured through the Covax/GAVI facility — a global vaccine procurement initiative backed by the World Health Organization (WHO), developed countries, and private donors to ensure fair distribution of vaccine across the world.

Read more at: https://jakartaglobe.id/news/indonesia-suspends-450000-astrazeneca-vaccine-doses-over-postvaccination-death